4D Molecular Therapeutics, Inc. FDMT

Full chart Compare
Set alert

Price alert · FDMT

All alert types
12.28 USD +0.33 (+2.76%)

At closeNov 4, 2026, 4:39 PM EST

12.28 0.00 0.00%

After hours · Nov 4, 4:39 PM ET

11.55 Day range 12.42
6.96 52-week range 16.93
YTD
+63.73%
1 year
+14.23%

Revenue & Expenses

Revenue by
Other Income → Expenses: $19.44MOther Operating Income → Expenses: $7.63MExpenses → Selling, General & Admin: $49.06MExpenses → Research & Development: $195.70MJapan → Revenue: $85.00MGross Profit → Expenses: $77.58MRevenue → Gross Profit: $77.58MRevenue → Cost of Revenue: $7.63MUnited States → Revenue: $209.00KNet Loss → Expenses: $140.11MOther Income$19.44MOther Operating Income$7.63MGross Profit$77.58MNet Loss$140.11MCost of Revenue$7.63MExpenses$244.76MSelling, General & Admin$49.06MResearch & Development$195.70MRevenue$85.21MJapan$85.00MUnited States$209.00K

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

FDMT annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
85.21M37.00K20.72M3.13M18.04M
85.21M37.00K20.72M3.13M18.04M
85.21M37.00K20.72M3.13M18.04M
244.76M187.88M133.59M113.16M89.37M
195.70M141.30M97.10M80.25M61.36M
49.06M46.58M36.49M32.91M28.01M
-159.55M-187.84M-112.87M-110.03M-71.33M
-140.11M-160.87M-100.84M-107.49M-71.32M
-140.11M-160.87M-100.84M-107.49M-71.32M
-140.11M-160.87M-100.84M-107.49M-71.32M
-140.11M-160.87M-100.84M-107.49M-71.32M
-2.42-2.98-2.58-3.32-2.57
-2.42-2.98-2.58-3.32-2.57
-2.42-2.98-2.58-3.32-2.57
-140.11M-160.87M-100.84M-107.49M-71.32M
-140.11M-160.87M-100.84M-107.49M-71.32M
57.93M53.94M39.13M32.35M27.73M
57.93M53.94M39.13M32.35M27.73M